Ron Squarer, Director at ADC Therapeutics, holds 6.28K shares in Nuvalent (Ticker: NUVL), holds 123.43K shares in ADC Therapeutics (Ticker: ADCT), holds 39.38K shares in Travere Therapeutics (Ticker: TVTX).
Ron Squarer latest transaction was an Uninformative Buy of ―.
What was Ron Squarer's most profitable transaction?
Ron Squarer’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ron Squarer's role in ADC Therapeutics?
Ron Squarer's role in ADC Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.